COMMUNIQUÉS West-GlobeNewswire

Stelis Biopharma and Oncobiologics to Unveil Bio2Source CDMO Offering at BIO 2018

04/06/2018 - 15:00

CRANBURY, N.J., June 04, 2018 (GLOBE NEWSWIRE) -- Stelis Biopharma and Oncobiologics, Inc. (NASDAQ:ONS) today announced that they will unveil a new contract development and manufacturing (“CDMO”) effort at BIO 2018 in [...]

CapsoVision Announces U.S. Distribution Partnership With PENTAX Medical

04/06/2018 - 15:00

The diagnostic and therapeutic endoscopy company will now sell CapsoVision capsule endoscopy solutions CapsoCam Plus® and CapsoCloud™ across the country SARATOGA, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Today Silicon [...]

Adverum Biotechnologies to Present at the 2018 Jefferies Global Healthcare Conference

04/06/2018 - 15:00

MENLO PARK, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, announced today [...]

"This is Infertility" Releases New Episodes for Pride Month 2018

04/06/2018 - 15:00

NEW YORK, June 04, 2018 (GLOBE NEWSWIRE) -- This is Infertility , a podcast by Progyny, announced today the release of new episodes for Pride Month 2018. One episode, each highlighting how LGBTQ couples navigate the [...]

Oncolytics Biotech® Announces Poster Presentation Demonstrating the Ability of REOLYSIN® to Promote and Predict Response to Checkpoint Inhibitors at ASCO 2018 Annual Meeting

04/06/2018 - 15:00

CALGARY, Alberta and SAN DIEGO, June 04, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX:ONC) (NASDAQ:ONCY), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]

New Data from Phase 1 Study of Ivosidenib or Enasidenib in Combination with Azacitidine Demonstrate Robust Responses and a Well Tolerated Safety Profile in Newly Diagnosed IDHm AML Patients

04/06/2018 - 15:00

- Safety Profile of Combination Therapies Consistent with Single Agent IDHm Inhibitors and Azacitidine - - ORR of 78%, CR Rate of 44% and CR/CRi/CRp Rate of 65% in the Ivosidenib Arm; Molecular Clearance Observed in 7 [...]

CytomX Therapeutics Presents Preliminary Clinical Proof-of-Concept Data from Probody™ Platform and CX-072 at 2018 ASCO Annual Meeting

04/06/2018 - 15:00

– PD-L1 Targeting Probody CX-072 Well Tolerated and Shows Antitumor Activity as Monotherapy and in Combination with Ipilimumab – – Company to Host Conference Call and Webcast Today Monday, June 4 th at 5:00 p.m. CT / 6: [...]

Analogic Announces Results for the Third Quarter Ended April 30, 2018

04/06/2018 - 15:00

Special Shareholder Meeting To Approve Altaris Transaction Scheduled for June 21, 2018 PEABODY, Mass., June 04, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and [...]

Galectin Therapeutics Inc. Announces Richard E. Uihlein Elected Chairman of the Board

04/06/2018 - 15:00

NORCROSS, Ga., June 04, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, announced today that the directors elected Richard E. [...]

SELLAS Life Sciences Presents Interim Phase 1 Clinical Data of Galinpepimut-S (GPS) in Combination with Nivolumab to Treat Wilms Tumor 1 Positive (WT1+) Ovarian Cancer Patients at ASCO 2018

04/06/2018 - 14:45

1-year progression-free survival (PFS) rate of 70% with induction of serum levels of WT1 Antigen-Specific Immunoglobulin G (IgG) in 86% of patients treated with GPS in combination with programmed cell death protein-1 ( [...]

Marrone Bio Innovations Launches New CG Brand of Highly Effective Biological Solutions for Crop Protection in Cannabis and Home Gardens

04/06/2018 - 14:31

Smaller package sizes of Regalia® CG, Grandevo® CG and Venerate® CG address the most economically damaging pests and diseases in cannabis production and for home gardeners DAVIS, Calif., June 04, 2018 (GLOBE NEWSWIRE [...]

Progenics Pharmaceuticals Announces Presentation of Updated Data from the Pivotal Trial of AZEDRA® (iobenguane I 131) at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

04/06/2018 - 14:30

NEW YORK, June 04, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and other products for targeting and treating cancer, announced updated [...]

New Interim Phase 2a Study Results Demonstrate Broad Clinical Activity of Portola Pharmaceuticals’ Oral SYK/JAK Inhibitor Cerdulatinib

04/06/2018 - 14:30

– Differentiated SYK-JAK Inhibitor Shows Efficacy in Patients with Heavily Pre-Treated B- and T-Cell Malignancies – – New Signal in AITL; Five Complete Responses for a Complete Response Rate of 71 Percent – – Data to be [...]

Natus Medical Board of Directors Mails Letter to Shareholders

04/06/2018 - 14:30

Recommends Voting on the WHITE Proxy Card FOR the Election of Doris Engibous and Robert Weiss Shareholders Should Not Vote for Removal of Chairman Robert Gunst Illustrates Highly-Qualified and Committed Directors with [...]

Interpace Diagnostics to Attend and Present at the 8th Annual LD Micro Invitational Conference

04/06/2018 - 14:30

PARSIPPANY, N.J., June 04, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically [...]

Oxford Immunotec Announces Data Presentations for T-SPOT®.CMV Test at the 2018 American Transplant Congress

04/06/2018 - 14:30

OXFORD, United Kingdom and MARLBOROUGH, Mass., June 04, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that data from studies utilizing the [...]

Daxor Corporation Initiates Study with Virginia Commonwealth University to Measure Improvement of Survival Rates Following Burn Surgery As A Result of Optimized Blood Volume Assessment

04/06/2018 - 14:30

NEW YORK, June 04, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) , an innovative medical instrumentation and biotechnology company focused on blood volume measurement today announces the initiation of an [...]

Sarepta Therapeutics Appoints Louise Rodino-Klapac, Ph.D. to Lead Newly Created Gene Therapy Business Unit

04/06/2018 - 14:30

-- Dr. Rodino-Klapac, a National Institutes of Health Fellow, is a pioneer in the advancement of gene therapy to treat human disease, whose discoveries have advanced six gene therapy programs from bench to human [...]

Cesca Therapeutics Announces Reduction in Operating Expenses

04/06/2018 - 14:30

RANCHO CORDOVA, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies [...]